Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now has funded $24,388,300 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 156 grants at over 100 hospitals in 29 countries.
The University of Alabama at Birmingham – $100,000
$100,000.00
December 2023
Intranasal Delivery of Targeting Nanotherapeutics for DIPG
Funding of PBTCF 2023 - $25,000
$25,000.00
December 2023
Children's Cancer Institute – $181,736 USD, $281,691 AUD
$181,736.00
November 2023
Targeting post-translational protein modification to halt Diffuse Intrinsic Pontine Glioma tumorgenicity
Memorial Sloan Kettering Cancer Center – $100,000
$100,000.00
November 2023
CSF Cell-free Tumor DNA (CSF cfDNA) Liquid Biopsies for Pediatric, Adolescent, and Young Adult Patients with Primary Brain Tumors
University of Colorado Denver – $200,000
$200,000.00
November 2023
Preclinical assessment of efficacy and specificity of logic-gated CAR-T cell therapy in Diffuse Intrinsic Pontine Glioma
SIOPe DIPG/DMG Registry – $715,852 USD, € 643,014
$715,852.00
November 2023
Renewal of the European DIPG/DMG Registry
Cincinnati Children's Hospital – $200,000
$200,000.00
November 2023
Targeting diffuse midline gliomas with innovative T cell immunotherapy
Cincinnati Children's Hospital – $50,000
$50,000.00
May 2023
Exploring Novel Targets In DIPG
University Medicine Göttingen – $50,000
$50,000.00
May 2023
Starve the monster: Multi-metabolic treatment strategies for H3.3K27M-mutant DIPG/DMG
Funding of PBTCF 2023 - $25,000
$25,000.00
January 2023
University of Queensland Diamantina Institute – $100,000
$100,000.00
November 2022
Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma
Erasmus University Medical Center – $432,354
$432,354.00
November 2022
Development and optimization of targeted radiopharmaceutical therapies for pediatric brain tumors; a world-first translational study. Acronym: TARGET-FIRST
Cincinnati Children's Hospital Medical Center – $60,000
$60,000.00
November 2022
Targeting Histone Lysine Demethylases to Treat Diffuse Intrinsic Pontine Glioma
Cincinnati Children's Hospital Medical Center – $153,867
$153,867.00
November 2022
Combining innovative proton radiotherapy with targeted and immune therapies to treat DMG/DIPG
Hunter Medical Research Institute – $232,932
$232,932.00
November 2022
Enhancing the recruitment of tumor infiltrating lymphocytes to improve responses to DMG therapies